New opportunities for nanoparticles in cancer immunotherapy
Abstract Background Recently, cancer immunotherapy has become standard for cancer treatment.Immunotherapy not only treats primary tumors, but also prevents metastasis and recurrence, representing a major advantage over conventional cancer treatments.However, existing cancer immunotherapies have limited clinical benefits because cancer antigens are